BEDFORD, Mass.--(BUSINESS WIRE)-- Augmenix, Inc. is pleased to announce that the company’s leading product, SpaceOAR hydrogel, is now available to millions of American men covered under Medicare, ...
Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, today ...
Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the ...
Tulavi Therapeutics has received a de novo clearance from the FDA for a surgical kit designed to help reduce long-term phantom limb pains among people who have had an amputation. The Allay nerve cap ...
AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its ...
AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results